Our mission is to help breast cancer patients live longer, better lives through earlier detection. We combine new deep learning methods, data science and radiology insights to help doctors find malignancies in mammograms. According to external clinical trial results, Kheiron’s deep learning technology achieves state-of-the-art malignancy detection support in breast cancer screening. European regulatory approval is expected shortly.
Is this your company?
If you're responsible for hiring at this company, make sure your company and job information are always up to date to attract top talent from the Greycroft network.
Something looks off?
Open jobs at Kheiron Medical